209 related articles for article (PubMed ID: 11927273)
1. Interleukin-5 and eosinophils as therapeutic targets for asthma.
Foster PS; Hogan SP; Yang M; Mattes J; Young IG; Matthaei KI; Kumar RK; Mahalingam S; Webb DC
Trends Mol Med; 2002 Apr; 8(4):162-7. PubMed ID: 11927273
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma.
Mattes J; Yang M; Mahalingam S; Kuehr J; Webb DC; Simson L; Hogan SP; Koskinen A; McKenzie AN; Dent LA; Rothenberg ME; Matthaei KI; Young IG; Foster PS
J Exp Med; 2002 Jun; 195(11):1433-44. PubMed ID: 12045241
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice.
Hogan SP; Koskinen A; Foster PS
Immunol Cell Biol; 1997 Jun; 75(3):284-8. PubMed ID: 9243294
[TBL] [Abstract][Full Text] [Related]
4. Airway hyperresponsiveness: first eosinophils and then neuropeptides.
Kraneveld AD; Folkerts G; Van Oosterhout AJ; Nijkamp FP
Int J Immunopharmacol; 1997; 19(9-10):517-27. PubMed ID: 9637348
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes.
Kanda A; Driss V; Hornez N; Abdallah M; Roumier T; Abboud G; Legrand F; Staumont-Sallé D; Quéant S; Bertout J; Fleury S; Rémy P; Papin JP; Julia V; Capron M; Dombrowicz D
J Allergy Clin Immunol; 2009 Sep; 124(3):573-82, 582.e1-9. PubMed ID: 19539982
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice.
Hogan SP; Koskinen A; Matthaei KI; Young IG; Foster PS
Am J Respir Crit Care Med; 1998 Jan; 157(1):210-8. PubMed ID: 9445302
[TBL] [Abstract][Full Text] [Related]
7. Role of IL-5 in the development of allergen-induced airway hyperresponsiveness.
Hamelmann E; Gelfand EW
Int Arch Allergy Immunol; 1999 Sep; 120(1):8-16. PubMed ID: 10529584
[TBL] [Abstract][Full Text] [Related]
8. Antibody against interleukin-5 prevents antigen-induced eosinophil infiltration and bronchial hyperreactivity in the guinea pig airways.
Akutsu I; Kojima T; Kariyone A; Fukuda T; Makino S; Takatsu K
Immunol Lett; 1995 Feb; 45(1-2):109-16. PubMed ID: 7622177
[TBL] [Abstract][Full Text] [Related]
9. Single and Synergistic Effects of Type 2 Cytokines on Eosinophils and Asthma Hallmarks.
Beckert H; Meyer-Martin H; Buhl R; Taube C; Reuter S
J Immunol; 2020 Feb; 204(3):550-558. PubMed ID: 31862712
[TBL] [Abstract][Full Text] [Related]
10. IL-5 and IL-5 receptor in asthma.
Kotsimbos AT; Hamid Q
Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():75-91. PubMed ID: 9698919
[TBL] [Abstract][Full Text] [Related]
11. The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity.
Mould AW; Ramsay AJ; Matthaei KI; Young IG; Rothenberg ME; Foster PS
J Immunol; 2000 Feb; 164(4):2142-50. PubMed ID: 10657668
[TBL] [Abstract][Full Text] [Related]
12. Distinct spatial requirement for eosinophil-induced airways hyperreactivity.
Webb DC; McKenzie AN; Matthaei KI; Rothenberg ME; Foster PS
Immunol Cell Biol; 2001 Apr; 79(2):165-9. PubMed ID: 11264712
[TBL] [Abstract][Full Text] [Related]
13. Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice.
Kobayashi T; Iijima K; Kita H
J Immunol; 2003 Jun; 170(11):5756-63. PubMed ID: 12759459
[TBL] [Abstract][Full Text] [Related]
14. Effect of Sch 55700, a humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivity.
Egan RW; Athwal D; Bodmer MW; Carter JM; Chapman RW; Chou CC; Cox MA; Emtage JS; Fernandez X; Genatt N; Indelicato SR; Jenh CH; Kreutner W; Kung TT; Mauser PJ; Minnicozzi M; Murgolo NJ; Narula SK; Petro ME; Schilling A; Sehring S; Stelts D; Stephens S; Taremi SS; Zurcher J
Arzneimittelforschung; 1999 Sep; 49(9):779-90. PubMed ID: 10514907
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.
Gavett SH; O'Hearn DJ; Li X; Huang SK; Finkelman FD; Wills-Karp M
J Exp Med; 1995 Nov; 182(5):1527-36. PubMed ID: 7595222
[TBL] [Abstract][Full Text] [Related]
16. A role for eosinophils in airway remodelling in asthma.
Kay AB; Phipps S; Robinson DS
Trends Immunol; 2004 Sep; 25(9):477-82. PubMed ID: 15324740
[TBL] [Abstract][Full Text] [Related]
17. [The role of interleukin 13 and interleukin 5 in asthma].
Tomasiak-Łozowska MM; Bodzenta-Łukaszyk A; Tomasiak M; Skiepko R; Zietkowski Z
Postepy Hig Med Dosw (Online); 2010 Mar; 64():146-55. PubMed ID: 20354262
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-4 and interleukin-5 as targets for the inhibition of eosinophilic inflammation and allergic airways hyperreactivity.
Foster PS; Hogan SP; Matthaei KI; Young IG
Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():55-61. PubMed ID: 9698916
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma.
Hilvering B; Xue L; Pavord ID
Ther Adv Respir Dis; 2015 Aug; 9(4):135-45. PubMed ID: 25900924
[TBL] [Abstract][Full Text] [Related]
20. Mepolizumab in the treatment of severe eosinophilic asthma.
Fainardi V; Pisi G; Chetta A
Immunotherapy; 2016; 8(1):27-34. PubMed ID: 26653083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
